Literature DB >> 27011423

The Biology of Hemodialysis Vascular Access Failure.

Akshaar Brahmbhatt1, Sanjay Misra2.   

Abstract

Arteriovenous fistulas (AVFs) are essential for patients and clinicians faced with end-stage renal disease (ESRD). While this method of vascular access for hemodialysis is preferred to others due to its reduced rate of infection and complications, they are plagued by intimal hyperplasia. The pathogenesis of intimal hyperplasia and subsequent thrombosis is brought on by uremia, hypoxia, and shear stress. These forces upregulate inflammatory and proliferative cytokines acting on leukocytes, fibroblasts, smooth muscle cells, and platelets. This activation begins initially with the progression of uremia, which induces platelet dysfunction and primes the body for an inflammatory response. The vasculature subsequently undergoes changes in oxygenation and shear stress during AVF creation. This propagates a strong inflammatory response in the vessel leading to cellular proliferation. This combined response is then further subjected to the stressors of cannulation and dialysis, eventually leading to stenosis and thrombosis. This review aims to help interventional radiologists understand the biological changes and pathogenesis of access failure.

Entities:  

Keywords:  arteriovenous fistula failure; end stage renal disease; hemodialysis; interventional radiology; intimal hyperplasia

Year:  2016        PMID: 27011423      PMCID: PMC4803510          DOI: 10.1055/s-0036-1572355

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  83 in total

1.  Effects of wall shear stress in venous neointimal hyperplasia of arteriovenous fistulae.

Authors:  Lan Jia; Lihua Wang; Fang Wei; Haibo Yu; Hongye Dong; Bo Wang; Zhi Lu; Guijiang Sun; Haiyan Chen; Jia Meng; Bo Li; Ruining Zhang; Xueqing Bi; Zhe Wang; Haiyan Pang; Aili Jiang
Journal:  Nephrology (Carlton)       Date:  2015-05       Impact factor: 2.506

2.  Prothrombotic changes in platelet, endothelial and coagulation function following hemodialysis.

Authors:  James A Milburn; Kevin Cassar; Isobel Ford; Nicholas Fluck; Julie Brittenden
Journal:  Int J Artif Organs       Date:  2011-03       Impact factor: 1.595

3.  Increasing AV fistulas: revisiting a time-tested solution.

Authors:  J J Sands
Journal:  Semin Dial       Date:  2000 Nov-Dec       Impact factor: 3.455

4.  Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.

Authors:  Y Erdem; I C Haznedaroglu; I Celik; A U Yalcin; U Yasavul; C Turgan; S Caglar
Journal:  Nephrol Dial Transplant       Date:  1996-07       Impact factor: 5.992

Review 5.  AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD?

Authors:  Hidenori Koyama; Yoshiki Nishizawa
Journal:  Eur J Clin Invest       Date:  2010-05-21       Impact factor: 4.686

6.  Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients.

Authors:  O A Paniagua; M B Bryant; J A Panza
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

7.  Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells.

Authors:  Kisho Ohtani; Kensuke Egashira; Ken-ichi Hiasa; Qingwei Zhao; Shiro Kitamoto; Minako Ishibashi; Makoto Usui; Shujiro Inoue; Yoshikazu Yonemitsu; Katsuo Sueishi; Masataka Sata; Masabumi Shibuya; Kenji Sunagawa
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

8.  Cross-talk between inflammation,coagulation/fibrinolysis and vascular access in hemodialysis patients.

Authors:  E Costa; S Rocha; P Rocha-Pereira; E Castro; F Reis; F Teixeira; V Miranda; M Do Sameiro Faria; A Loureiro; A Quintanilha; L Belo; A Santos-Silva
Journal:  J Vasc Access       Date:  2008 Oct-Dec       Impact factor: 2.283

9.  CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas.

Authors:  Taku Kokubo; Noriyuki Ishikawa; Hisashi Uchida; Sara E Chasnoff; Xun Xie; Suresh Mathew; Keith A Hruska; Eric T Choi
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

10.  Thrombin-anti-thrombin levels and patency of arterio-venous fistula in patients undergoing haemodialysis compared to healthy volunteers: a prospective analysis.

Authors:  James A Milburn; Isobel Ford; Nicola J Mutch; Nicholas Fluck; Julie Brittenden
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more
  5 in total

1.  Molecular Targets for Improving Arteriovenous Fistula Maturation and Patency.

Authors:  Jolanta Gorecka; Arash Fereydooni; Luis Gonzalez; Shin Rong Lee; Shirley Liu; Shun Ono; Jianbiao Xu; Jia Liu; Ryosuke Taniguchi; Yutaka Matsubara; Xixiang Gao; Mingjie Gao; John Langford; Bogdan Yatsula; Alan Dardik
Journal:  Vasc Investig Ther       Date:  2019-10-09

2.  Heme Oxygenase 1/Peroxisome Proliferator-Activated Receptor Gamma Pathway Protects Intimal Hyperplasia and Mitigates Arteriovenous Fistula Dysfunction by Regulating Oxidative Stress and Inflammatory Response.

Authors:  Tingfei Xie; Yunpeng Xu; Lecai Ji; Xiaolu Sui; Aisha Zhang; Yanzi Zhang; Jihong Chen
Journal:  Cardiovasc Ther       Date:  2022-06-12       Impact factor: 3.368

3.  Transcriptional and Epigenetic Factors Associated with Early Thrombosis of Femoral Artery Involved in Arteriovenous Fistula.

Authors:  Vikrant Rai; Devendra K Agrawal
Journal:  Proteomes       Date:  2022-04-30

4.  Development and validation of a risk score to prioritize patients for evaluation of access stenosis.

Authors:  Brad C Astor; Kim Hirschman; John Kennedy; Stan Frinak; Anatole Besarab
Journal:  Semin Dial       Date:  2021-10-12       Impact factor: 2.886

5.  Periadventitial Delivery of Simvastatin-Loaded Microparticles Attenuate Venous Neointimal Hyperplasia Associated With Arteriovenous Fistula.

Authors:  Chenglei Zhao; Sean T Zuckerman; Chuanqi Cai; Sreenivasulu Kilari; Avishek Singh; Michael Simeon; Horst A von Recum; Julius N Korley; Sanjay Misra
Journal:  J Am Heart Assoc       Date:  2020-12-05       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.